# Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

> **NCT02315898** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 40 (actual)

## Conditions studied

- Plastic Bronchitis
- Protein-Losing Enteropathies
- Healthy

## Interventions

- **DRUG:** Treatment-inhaled tPA

## Key facts

- **NCT ID:** NCT02315898
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-19
- **Primary completion:** 2021-03-05
- **Final completion:** 2023-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02315898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02315898, "Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02315898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*